BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 29527925)

  • 1. Synthesis of nanomedicines by nanohybrids conjugating ginsenosides with auto-targeting and enhanced MRI contrast for liver cancer therapy.
    Zhao X; Wang J; Song Y; Chen X
    Drug Dev Ind Pharm; 2018 Aug; 44(8):1307-1316. PubMed ID: 29527925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel bioactive nanoparticle synthesized by conjugation of 3-chloropropyl trimethoxy silane functionalized Fe
    Habibzadeh SZ; Salehzadeh A; Moradi-Shoeili Z; Shandiz SAS
    Mol Biol Rep; 2020 Mar; 47(3):1637-1647. PubMed ID: 31933263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tumor-targeting core-shell structured DTX-loaded PLGA@Au nanoparticles for chemo-photothermal therapy and X-ray imaging.
    Hao Y; Zhang B; Zheng C; Ji R; Ren X; Guo F; Sun S; Shi J; Zhang H; Zhang Z; Wang L; Zhang Y
    J Control Release; 2015 Dec; 220(Pt A):545-555. PubMed ID: 26590021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T
    Li J; You J; Wu C; Dai Y; Shi M; Dong L; Xu K
    Int J Nanomedicine; 2018; 13():4607-4625. PubMed ID: 30127609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronic acid-modified hydrothermally synthesized iron oxide nanoparticles for targeted tumor MR imaging.
    Li J; He Y; Sun W; Luo Y; Cai H; Pan Y; Shen M; Xia J; Shi X
    Biomaterials; 2014 Apr; 35(11):3666-77. PubMed ID: 24462358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-pot synthesis of iron oxide nanoparticles with functional silane shells: a versatile general precursor for conjugations and biomedical applications.
    Yathindranath V; Sun Z; Worden M; Donald LJ; Thliveris JA; Miller DW; Hegmann T
    Langmuir; 2013 Aug; 29(34):10850-8. PubMed ID: 23906380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific targeting of cancer cells by multifunctional mitoxantrone-conjugated magnetic nanoparticles.
    Heidari Majd M; Asgari D; Barar J; Valizadeh H; Kafil V; Coukos G; Omidi Y
    J Drug Target; 2013 May; 21(4):328-40. PubMed ID: 23293842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organic and inorganic nano-Fe
    Mashjoor S; Yousefzadi M; Zolgharnain H; Kamrani E; Alishahi M
    Environ Pollut; 2018 Jun; 237():50-64. PubMed ID: 29474987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational design of magnetic nanorattles as contrast agents for ultrasound/magnetic resonance dual-modality imaging.
    Yang P; Wang F; Luo X; Zhang Y; Guo J; Shi W; Wang C
    ACS Appl Mater Interfaces; 2014 Aug; 6(15):12581-7. PubMed ID: 25022424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In situ preparation of water-soluble ginsenoside Rh2-entrapped bovine serum albumin nanoparticles: in vitro cytocompatibility studies.
    Singh P; Kim YJ; Singh H; Ahn S; Castro-Aceituno V; Yang DC
    Int J Nanomedicine; 2017; 12():4073-4084. PubMed ID: 28603419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theranostic nanoparticles based on magnetic nanoparticles: design, preparation, characterization, and evaluation as novel anticancer drug carrier and MRI contrast agent.
    Nosrati H; Salehiabar M; Kheiri Manjili H; Davaran S; Danafar H
    Drug Dev Ind Pharm; 2018 Oct; 44(10):1668-1678. PubMed ID: 29848101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging specificity of MR-optical imaging agents following the masking of surface charge by poly(ethylene glycol).
    Wu SC; Lin KL; Wang TP; Tzou SC; Singh G; Chen MH; Cheng TL; Chen CY; Liu GC; Lee TW; Hu SH; Wang YM
    Biomaterials; 2013 May; 34(16):4118-4127. PubMed ID: 23465830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodegradable double-targeted PTX-mPEG-PLGA nanoparticles for ultrasound contrast enhanced imaging and antitumor therapy in vitro.
    Ma J; Shen M; Xu CS; Sun Y; Duan YR; Du LF
    Oncotarget; 2016 Nov; 7(48):80008-80018. PubMed ID: 27835907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-Specific Endogenous Fe
    Fan Z; Jiang B; Zhu Q; Xiang S; Tu L; Yang Y; Zhao Q; Huang D; Han J; Su G; Ge D; Hou Z
    ACS Appl Mater Interfaces; 2020 Apr; 12(13):14884-14904. PubMed ID: 32167740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid-coated iron oxide nanoparticles for dual-modal imaging of hepatocellular carcinoma.
    Liang J; Zhang X; Miao Y; Li J; Gan Y
    Int J Nanomedicine; 2017; 12():2033-2044. PubMed ID: 28352173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biopanning and characterization of peptides with Fe3O4 nanoparticles-binding capability via phage display random peptide library technique.
    You F; Yin G; Pu X; Li Y; Hu Y; Huang Z; Liao X; Yao Y; Chen X
    Colloids Surf B Biointerfaces; 2016 May; 141():537-545. PubMed ID: 26896661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor selectivity of stealth multi-functionalized superparamagnetic iron oxide nanoparticles.
    Fan C; Gao W; Chen Z; Fan H; Li M; Deng F; Chen Z
    Int J Pharm; 2011 Feb; 404(1-2):180-90. PubMed ID: 21087660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and functionalization of protease-activated nanoparticles with tissue plasminogen activator peptides as targeting moiety and diagnostic tool for pancreatic cancer.
    Dobiasch S; Szanyi S; Kjaev A; Werner J; Strauss A; Weis C; Grenacher L; Kapilov-Buchman K; Israel LL; Lellouche JP; Locatelli E; Franchini MC; Vandooren J; Opdenakker G; Felix K
    J Nanobiotechnology; 2016 Dec; 14(1):81. PubMed ID: 27993133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Multi-Functional Tumor Theranostic Nanoplatform for MRI Guided Photothermal-Chemotherapy.
    Shi J; Wang B; Chen Z; Liu W; Pan J; Hou L; Zhang Z
    Pharm Res; 2016 Jun; 33(6):1472-85. PubMed ID: 26984128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxygen plasma-fragmented KMnF
    Fu X; Yu LL; Li YS; Zhang Y; Xiao XP; Zhang JS; Shu T; Cai J; Tang Q
    Nanotechnology; 2018 Sep; 29(36):365601. PubMed ID: 29889044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.